Since PD-1/PD-L1 does not induce T cell infiltration into tumors, but rather rescues/prevents T cell anergy, it is not surprising that patients associated with the best responses possess higher tumor-infiltrating T cell levels prior to treatment that is co-localized with PD-L1 expression.54 The gene discussed is CD274; the disease is neoplasm.